Overview
Bifonazole is an azole antifungal drug.
Indication
Used for the treatment of various topical fungal infections, including athlete's foot (tinea pedis).
Associated Conditions
- Fungal Infections
- Fungal infection of nail
- Fungal skin infection
- Infections, Fungal of the Skin Folds
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2016/03/10 | Phase 4 | Completed | |||
2009/11/16 | Phase 2 | Completed | |||
2008/10/29 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| CANESPRO ONCE DAILY CREAM 1% | SIN15415P | CREAM | 1.00% | 2/1/2018 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CANESTEN ONCE DAILY BIFONAZOLE ANTIFUNGAL CREAM 1% bifonazole 10mg/g cream tube | 179473 | Medicine | A | 1/25/2011 | |
| CANESTEN ONCE DAILY BIFONAZOLE ATHLETE'S FOOT CREAM 1%w/w tube | 63479 | Medicine | A | 3/26/1998 | |
| Canesten Once Daily Antifungal Athlete's Foot Cream 1%w/w tube with applicator | 326403 | Medicine | A | 11/20/2019 | |
| CANESTEN ONCE DAILY BIFONAZOLE BODY CREAM 1% w/w tube | 80846 | Medicine | A | 11/8/2001 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| LEVELINA 10 mg/g CREMA | Laboratorios Ern S.A. | 58476 | CREMA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| CANESPIE BIFONAZOL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | Bayer Hispania S.L. | 57304 | SOLUCIÓN CUTÁNEA | Sin Receta | Commercialized |
| LEVELINA 10 mg/g POLVO CUTANEO | Laboratorios Ern S.A. | 58479 | POLVO CUTÁNEO | Medicamento Sujeto A Prescripción Médica | Commercialized |
| CANESMYCOSPOR ONICOSET 10mg/ g + 400mg/g POMADA | Bayer Hispania S.L. | 59748 | POMADA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| CANESMYCOSPOR 10 mg/g CREMA | Bayer Hispania S.L. | 57303 | CREMA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| CANESPIE BIFONAZOL 10 mg/g CREMA | Bayer Hispania S.L. | 74651 | CREMA | Sin Receta | Commercialized |
| LEVELINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | Laboratorios Ern S.A. | 58478 | SOLUCIÓN CUTÁNEA | Medicamento Sujeto A Prescripción Médica | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.